Mindfulness Relapse Prevention for Smoking and Alcohol in Cancer Survivors

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The trial compares MBRP-SA to standard care for adults with a history of cancer who smoke and engage in at-risk alcohol use. It will include brain-behavior-focused interventions delivered across medical centers and community settings in Florida, with additional analyses on cost, implementation, and potential moderators of treatment effects. Researchers will gather stakeholder input through structured interviews and perform an incremental cost-effectiveness analysis. The study will also explore how and for whom the intervention works best, aiming to inform future adoption in cancer care.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* ≥18 years old
* History of a cancer diagnosis at any point in lifetime
* Smoked ≥1 cigarette/day in past month
* At least one binge drinking episode in past month or exceeds weekly drinking limits
* Motivated to quit smoking and modify alcohol use in next 30 days
* Valid home address in Florida
* English-speaking, reading, and writing ability

Exclusion Criteria:

* Pregnancy or lactation
* Active psychotic disorder
* History of severe alcohol withdrawal
* Current use of tobacco cessation medication or other treatments to quit smoking
* End-of-life or hospice care
* Household member already enrolled

Where it's running

• Moffitt Cancer Center
  Tampa, Florida, United States Recruiting

Study contacts

• Principal investigator: Christine Vinci, PhD — Moffitt Cancer Center
• Study coordinator: Skye Dougan, MPH
• Email: Skye.Dougan@moffitt.org
• Phone: 813-745-4376

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Quitting Matters: a smoking quit program for people living with HIV

  This 6-month program will test whether a tailored smartphone app plus nicotine patches and gum helps people living with HIV quit smoking better than a standard quit app.

  Recruiting Wake Forest University Health Sciences · Winston-Salem, North Carolina · NCT06883097

• Smoky Futures: Danish Adolescent Nicotine Use over Time

  This observational cohort follows Danish youths ages 15–25 to see how cigarette, e-cigarette, and other nicotine use begin, change, and affect health and education over several years.

  Recruiting University of Southern Denmark · Copenhagen · NCT07910331

• Nicotine Orodispersible Tablet to Relieve Cravings in Smokers

  A nicotine mint orodispersible tablet is tested vs placebo to see if it quickly eases the urge to smoke in adult cigarette smokers.

  Recruiting Phase 2 Kenvue Brands LLC · Mississauga, Ontario · NCT07893158

• Optimizing when weekly chatbot reminders go out to people using a chatbot for quitting smoking

  This study tests whether sending weekly reminders at different times helps people stay engaged with a chatbot smoking-cessation service.

  Recruiting The University of Hong Kong · Hong Kong · NCT07826884

• NMDA and Sigma-1 combination therapy for smoking cessation with AXS-05

  This phase 3 trial tests whether AXS-05 can help adults quit smoking better than placebo or bupropion.

  Recruiting at 28 sites Phase 3 Axsome Therapeutics, Inc. · Phoenix, Arizona and 27 other locations · NCT07766655

• Smartphone-based Intervention for Young Adults with ADHD and Risky Drinking

  A smartphone-based program is tested to see if it's doable and helpful for young adults with ADHD who also drink at risky levels.

  Recruiting University of Pittsburgh · Pittsburgh, Pennsylvania · NCT07654205

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.